S. Çelik Et Al. , "Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy," Indian Journal of Hematology and Blood Transfusion , vol.38, no.2, pp.282-289, 2022
Çelik, S. Et Al. 2022. Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy. Indian Journal of Hematology and Blood Transfusion , vol.38, no.2 , 282-289.
Çelik, S., Kaynar, L., Güven, Z. T., BAYDAR, M., KEKLİK, M., Çetin, M., ... ÜNAL, A.(2022). Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy. Indian Journal of Hematology and Blood Transfusion , vol.38, no.2, 282-289.
Çelik, Serhat Et Al. "Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy," Indian Journal of Hematology and Blood Transfusion , vol.38, no.2, 282-289, 2022
Çelik, Serhat Et Al. "Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy." Indian Journal of Hematology and Blood Transfusion , vol.38, no.2, pp.282-289, 2022
Çelik, S. Et Al. (2022) . "Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy." Indian Journal of Hematology and Blood Transfusion , vol.38, no.2, pp.282-289.
@article{article, author={Serhat Çelik Et Al. }, title={Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy}, journal={Indian Journal of Hematology and Blood Transfusion}, year=2022, pages={282-289} }